Category:
Anti-neoplastic Drugs and Immunomodulators
Generic Name:
Letrozole Tablets
Brand Name (Trademark):
予新®
Strength:
2.5mg
Indication:
1. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
2. Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy.
3. First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer.
